Potential predictors of outcomes among hospitalized COVID-19 patients treated with convalescent plasma: a single-center study

References

• Zhu N, Zhang D, Wang W, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020;382(8):727–733.
   PubMed Web of Science ®Google Scholar
• Brown BL, McCullough J. Treatment for emerging viruses: convalescent plasma and COVID-19. Transfus Apher Sci. 2020;59(3):102790.
   PubMed Web of Science ®Google Scholar
• Garraud O, Heshmati F, Pozzetto B, et al. Plasma therapy against infectious pathogens, as of yesterday, today and tomorrow. Transfus Clin Biol. 2016;23(1):39–44.
   Web of Science ®Google Scholar
• Shakir EM, Cheung DS, Grayson MH. Mechanisms of immunotherapy: a historical perspective. Ann Allergy Asthma Immunol. 2010;105(5):340–7; quiz 8, 68.
   Web of Science ®Google Scholar
• U.S. Food and Drug Administration. Recommendations for investigational COVID-19 convalescent plasma. 2021. Available from: https://www.fda.gov/vaccines-blood-biologics/investigational-new-drug-ind-or-device-exemption-ide-process-cber/recommendations-investigational-covid-19-convalescent-plasma. Cited 2021 Mar 28
   Google Scholar
• PlasmAr Study Group; Simonovich VA, Burgos Pratx LD, Scibona P, et al. A randomized trial of convalescent plasma in COVID-19 severe pneumonia. N Engl J Med. 2021;384(7):619–629.
   Web of Science ®Google Scholar
• Libster R, Pérez Marc G, Wappner D, et al. Early high-titer plasma therapy to prevent severe COVID-19 in older adults. N Engl J Med. 2021;384(7):610–618.
   PubMed Web of Science ®Google Scholar
• Li L, Zhang W, Hu Y, et al. Effect of convalescent plasma therapy on time to clinical improvement in patients with severe and life-threatening COVID-19: a randomized clinical trial. JAMA. 2020. Aug 4;324(5):460-470. doi: 10.1001/jama.2020.10044.
   Web of Science ®Google Scholar
• Joyner MJ, Carter RE, Senefeld JW, et al. Convalescent plasma antibody levels and the risk of death from COVID-19. N Engl J Med. 2021;384:1015–1027.
   PubMed Web of Science ®Google Scholar
• Joyner MJ, Bruno KA, Klassen SA, et al. Safety update: COVID-19 convalescent plasma in 20,000 hospitalized patients. Mayo Clin Proc. 2020;95(9):1888–1897.
   PubMed Web of Science ®Google Scholar
• Price-Haygood EG, Burton J, Fort D, et al. Hospitalization and mortality among black patients and white patients with COVID-19. N Engl J Med. 2020. DOI:10.1056/nejmsa2011686externalicon
   Web of Science ®Google Scholar
• Millet GA, Jones AT, Benkeser D, et al. Assessing differential impacts of COVID-19 on black communities. Ann Epidemiol. 2020;47:37–44.
   PubMed Web of Science ®Google Scholar
• Berchick ER, Barnett JC,Upton RD. Current population reports, P60-267(RV), health insurance coverage in the USA: 2018. Washington, DC: U.S. Government Printing Office; 2019.
   Google Scholar
• Institute of Medicine (US) Committee on the Consequences of Uninsurance. Care Without Coverage: too Little, Too Late. Washington (DC): National Academies Press (US); 2002.
   Google Scholar
• U.S. Bureau of Labor Statistics. Labor force characteristics by race and ethnicity, 2018 [online]. 2019. [cited 2021 Apr 8]. Available from: https://www.bls.gov/opub/reports/race-and-ethnicity/2018/home.htm
   Google Scholar
• The Annie E. Casey Foundation. Unequal Opportunities in Education [online]. 2006. [cited 2021 Apr 8]. Available from: https://www.aecf.org/m/resourcedoc/aecf-racemattersEDUCATION-2006.pdf
   Google Scholar
• Li Q, Guan X, Wu P, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med. 2020;382:1199–1207.
   PubMed Web of Science ®Google Scholar
• Yang X, Yu Y, Xu J, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. 2020;8:475–481.
   PubMed Web of Science ®Google Scholar
• Gebhard C, Regitz-Zagrosek V, Neuhauser HK, et al. Impact of sex and gender on COVID-19 outcomes in Europe. Biol Sex Differ. 2020;11:29.
   PubMed Web of Science ®Google Scholar
• Schiffer VMMM, Janssen EBNJ, Van Bussel BCT, et al. The “sex gap” in COVID-19 trials: a scoping review. EClinicalMedicine. 2020;29:100652.
   Google Scholar
• Mehew J, Johnson R, Roberts D, et al. Convalescent plasma for COVID-19: male gender, older age and hospitalisation associated with high neutralising antibody levels, England, 22 April to 12 May 2020. Euro Surveill. 2020;25(45):2001754.
   Google Scholar
• Scully EP, Haverfield J, Ursin RL, et al. Considering how biological sex impacts immune responses and COVID-19 outcomes. Nat Rev Immunol. 2020;20(7):442–447.
   PubMed Web of Science ®Google Scholar
• Igase M, Kohara K, Nagai T, et al. Increased expression of angiotensin converting enzyme 2 in conjunction with reduction of neointima by angiotensin II type 1 receptor blockade. Hypertens Res. 2008;31:553–559.
   PubMed Web of Science ®Google Scholar
• Ferrario CM, Jessup J, Chappell MC, et al. Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2. Circulation. 2005;111:2605–2610.
   PubMed Web of Science ®Google Scholar
• Lopes RD, Macedo AVS, De Barros E Silva PGM, et al. Effect of discontinuing vs continuing angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on days alive and out of the hospital in patients admitted with COVID-19: a randomized clinical trial. JAMA. 2021;325(3):254–264.
   PubMed Web of Science ®Google Scholar
• Biswas M, Kali MSK. Association of angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers with risk of mortality, severity or SARS-CoV-2 test positivity in COVID-19 patients: meta-analysis. Sci Rep. 2021;11:5012.
   PubMed Web of Science ®Google Scholar
• Lee SC, Son KJ, Han CH, et al. Impact of COPD on COVID-19 prognosis: a nationwide population-based study in South Korea. Sci Rep. 2021;11:3735.
   PubMed Web of Science ®Google Scholar
• Choi YJ, Park JY, Lee HS, et al. Effect of asthma and asthma medication on the prognosis of patients with COVID-19. Eur Respir J. 2021;57(3):2002226.
   PubMed Web of Science ®Google Scholar
• Hussein MH, Toraih EA, Attia AS, et al. Asthma in COVID-19 patients: an extra chain fitting around the neck? Respir Med. 2020;175:106205.
   PubMed Web of Science ®Google Scholar